Search details
1.
Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation.
Blood
; 112(10): 4170-7, 2008 Nov 15.
Article
in English
| MEDLINE | ID: mdl-18583569
Results
1 -
1
de 1
1
Next >
>>